Skip to main content
Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology 5/2016

12.03.2016 | Cornea

Prevalence of ocular hypertension and glaucoma in patients with chronic ocular graft-versus-host disease

verfasst von: Ujwala S. Saboo, Francisco Amparo, Hasanain Shikari, Reza Dana

Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology | Ausgabe 5/2016

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To evaluate the prevalence of ocular hypertension (OHT) and glaucoma in patients with chronic ocular graft-versus-host disease (GVHD).

Methods

We performed a retrospective chart review of 218 patients diagnosed with chronic ocular GVHD. Ocular hypertension was defined as intraocular pressure (IOP) ≥ 24 mmHg in either eye without any glaucomatous optic disc changes. Glaucoma suspect was defined as optic disc changes with a cup-to-disc ratio ≥ 0.7 in either eye or asymmetry of ≥ 0.3 between the two eyes. Glaucoma was defined by glaucomatous optic disc changes plus glaucomatous visual field defects in two consecutive reliable visual field tests. The number of cases of ocular hypertension, glaucoma, and glaucoma suspects was evaluated.

Results

Thirty-three patients (15 %) were diagnosed with OHT, eight patients (3.6 %) with suspicion of glaucoma, and one patient (0.4 %) with glaucoma. OHT occurred within 6 months of developing ocular GVHD in 60 % of the cases and within the first year in 76 %. High IOP normalized in 67 % of patients when the dosage of topical or systemic corticosteroids was lowered, and 27 % of patients required anti-glaucoma therapy.

Conclusions

Ocular hypertension is a common complication in patients with ocular GVHD, with a prevalence of 15 %. The rise in intraocular pressure is often transient and resolves with management of corticosteroids in most cases. However, clinicians should be aware that nearly one-third of the patients with OHT might require anti-glaucoma treatment. The prevalences of glaucoma and suspicion of glaucoma were not higher than in the general population.
Literatur
2.
Zurück zum Zitat Thomas ED, Clift RA, Storb R (1984) Indications for marrow transplantation. Annu Rev Med 35:1–9CrossRefPubMed Thomas ED, Clift RA, Storb R (1984) Indications for marrow transplantation. Annu Rev Med 35:1–9CrossRefPubMed
3.
Zurück zum Zitat Kansu E (2004) The pathophysiology of chronic graft-versus-host disease. Int J Hematol 79:209–215CrossRefPubMed Kansu E (2004) The pathophysiology of chronic graft-versus-host disease. Int J Hematol 79:209–215CrossRefPubMed
4.
Zurück zum Zitat Pallua S, Giesinger J, Oberguggenberger A et al (2010) Impact of GvHD on quality of life in long-term survivors of haematopoietic transplantation. Bone Marrow Transplant 45:1534–1539CrossRefPubMed Pallua S, Giesinger J, Oberguggenberger A et al (2010) Impact of GvHD on quality of life in long-term survivors of haematopoietic transplantation. Bone Marrow Transplant 45:1534–1539CrossRefPubMed
5.
Zurück zum Zitat Shikari H, Antin JH, Dana R (2013) Ocular graft-versus-host disease: a review. Surv Ophthalmol 58:233–251CrossRefPubMed Shikari H, Antin JH, Dana R (2013) Ocular graft-versus-host disease: a review. Surv Ophthalmol 58:233–251CrossRefPubMed
6.
Zurück zum Zitat Hessen M, Akpek EK (2012) Ocular graft-versus-host disease. Curr Opin Allergy Clin Immunol 12:540–547CrossRefPubMed Hessen M, Akpek EK (2012) Ocular graft-versus-host disease. Curr Opin Allergy Clin Immunol 12:540–547CrossRefPubMed
7.
Zurück zum Zitat Espana EM, Shah S, Santhiago MR, Singh AD (2013) Graft versus host disease: clinical evaluation, diagnosis and management. Graefes Arch Clin Exp Ophthalmol 251:1257–1266CrossRefPubMed Espana EM, Shah S, Santhiago MR, Singh AD (2013) Graft versus host disease: clinical evaluation, diagnosis and management. Graefes Arch Clin Exp Ophthalmol 251:1257–1266CrossRefPubMed
8.
Zurück zum Zitat Ogawa Y, Kuwana M (2003) Dry eye as a major complication associated with chronic graft-versus-host disease after hematopoietic stem cell transplantation. Cornea 22:S19-2CrossRef Ogawa Y, Kuwana M (2003) Dry eye as a major complication associated with chronic graft-versus-host disease after hematopoietic stem cell transplantation. Cornea 22:S19-2CrossRef
9.
10.
Zurück zum Zitat Tsai JH, Derby E, Holland EJ, Khatana AK (2006) Incidence and prevalence of glaucoma in severe ocular surface disease. Cornea 25:530–532CrossRefPubMed Tsai JH, Derby E, Holland EJ, Khatana AK (2006) Incidence and prevalence of glaucoma in severe ocular surface disease. Cornea 25:530–532CrossRefPubMed
11.
Zurück zum Zitat Ang M, Ti SE, Loh R et al (2012) Steroid-induced ocular hypertension in Asian children with severe vernal keratoconjunctivitis. Clin Ophthalmol 6:1253–1258CrossRefPubMedPubMedCentral Ang M, Ti SE, Loh R et al (2012) Steroid-induced ocular hypertension in Asian children with severe vernal keratoconjunctivitis. Clin Ophthalmol 6:1253–1258CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Tauber J, Melamed S, Foster CS (1989) Glaucoma in patients with ocular cicatricial pemphigoid. Ophthalmology 96:33–37CrossRefPubMed Tauber J, Melamed S, Foster CS (1989) Glaucoma in patients with ocular cicatricial pemphigoid. Ophthalmology 96:33–37CrossRefPubMed
13.
Zurück zum Zitat Yuki K, Shimmura S, Shiba D, Tsubota K (2009) End-stage glaucoma in Stevens–Johnson syndrome. Jpn J Ophthalmol 53:68–70CrossRefPubMed Yuki K, Shimmura S, Shiba D, Tsubota K (2009) End-stage glaucoma in Stevens–Johnson syndrome. Jpn J Ophthalmol 53:68–70CrossRefPubMed
14.
Zurück zum Zitat Jones R 3rd, Rhee DJ (2006) Corticosteroid-induced ocular hypertension and glaucoma: a brief review and update of the literature. Curr Opin Ophthalmol 17:163–167PubMed Jones R 3rd, Rhee DJ (2006) Corticosteroid-induced ocular hypertension and glaucoma: a brief review and update of the literature. Curr Opin Ophthalmol 17:163–167PubMed
15.
Zurück zum Zitat Batra R, Tailor R, Mohamed S (2014) Ocular surface disease exacerbated glaucoma: optimizing the ocular surface improves intraocular pressure control. J Glaucoma 23:56–60CrossRefPubMed Batra R, Tailor R, Mohamed S (2014) Ocular surface disease exacerbated glaucoma: optimizing the ocular surface improves intraocular pressure control. J Glaucoma 23:56–60CrossRefPubMed
16.
Zurück zum Zitat Shikari H, Amparo F, Saboo U, Dana R (2015) Onset of ocular graft-versus-host disease symptoms after allogeneic hematopoietic stem cell transplantation. Cornea 34:243–247PubMedPubMedCentral Shikari H, Amparo F, Saboo U, Dana R (2015) Onset of ocular graft-versus-host disease symptoms after allogeneic hematopoietic stem cell transplantation. Cornea 34:243–247PubMedPubMedCentral
17.
Zurück zum Zitat Kass MA, Heuer DK, Higginbotham EJ et al (2002) The ocular hypertension treatment study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol 120:701–713CrossRefPubMed Kass MA, Heuer DK, Higginbotham EJ et al (2002) The ocular hypertension treatment study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol 120:701–713CrossRefPubMed
18.
Zurück zum Zitat Katz LJ, Rauchman SH, Cottingham AJ Jr et al (2012) Fixed-combination brimonidine-timolol versus latanoprost in glaucoma and ocular hypertension: a 12-week, randomized, comparison study. Curr Med Res Opin 28:781–788CrossRefPubMed Katz LJ, Rauchman SH, Cottingham AJ Jr et al (2012) Fixed-combination brimonidine-timolol versus latanoprost in glaucoma and ocular hypertension: a 12-week, randomized, comparison study. Curr Med Res Opin 28:781–788CrossRefPubMed
19.
Zurück zum Zitat Pershing S, Bakri SJ, Moshfeghi DM (2013) Ocular hypertension and intraocular pressure asymmetry after intravitreal injection of anti-vascular endothelial growth factor agents. Ophthalmic Surg Lasers Imaging Retina 44:460–464CrossRefPubMed Pershing S, Bakri SJ, Moshfeghi DM (2013) Ocular hypertension and intraocular pressure asymmetry after intravitreal injection of anti-vascular endothelial growth factor agents. Ophthalmic Surg Lasers Imaging Retina 44:460–464CrossRefPubMed
20.
Zurück zum Zitat Kymes SM, Kass MA, Anderson DR et al (2006) Ocular Hypertension Treatment Study Group (OHTS). Management of ocular hypertension: a cost-effectiveness approach from the Ocular Hypertension Treatment Study. Am J Ophthalmol 141:997–1008CrossRefPubMedPubMedCentral Kymes SM, Kass MA, Anderson DR et al (2006) Ocular Hypertension Treatment Study Group (OHTS). Management of ocular hypertension: a cost-effectiveness approach from the Ocular Hypertension Treatment Study. Am J Ophthalmol 141:997–1008CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Mitchell P, Smith W, Attebo K, Healey PR (1996) Prevalence of open-angle glaucoma in Australia. The Blue Mountains Eye Study. Ophthalmology 103:1661–1669CrossRefPubMed Mitchell P, Smith W, Attebo K, Healey PR (1996) Prevalence of open-angle glaucoma in Australia. The Blue Mountains Eye Study. Ophthalmology 103:1661–1669CrossRefPubMed
22.
Zurück zum Zitat Crowston JG, Hopley CR, Healey PR (2004) The effect of optic disc diameter on vertical cup to disc ratio percentiles in a population-based cohort: the Blue Mountains Eye Study. Br J Ophthalmol 88:766–770CrossRefPubMedPubMedCentral Crowston JG, Hopley CR, Healey PR (2004) The effect of optic disc diameter on vertical cup to disc ratio percentiles in a population-based cohort: the Blue Mountains Eye Study. Br J Ophthalmol 88:766–770CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Ayansiji AA, Olasunkanmi OF, Olarongbe MA et al (2008) Clinical findings among Nigerian paediatric glaucoma suspects during a school eye health survey. Open Ophthalmol J 2(2):137–140 Ayansiji AA, Olasunkanmi OF, Olarongbe MA et al (2008) Clinical findings among Nigerian paediatric glaucoma suspects during a school eye health survey. Open Ophthalmol J 2(2):137–140
24.
Zurück zum Zitat Leske MC, Connell AM, Schachat AP et al (1994) The Barbados Eye Study. Prevalence of open angle glaucoma. Arch Ophthalmol 112:821–829CrossRefPubMed Leske MC, Connell AM, Schachat AP et al (1994) The Barbados Eye Study. Prevalence of open angle glaucoma. Arch Ophthalmol 112:821–829CrossRefPubMed
25.
Zurück zum Zitat Brusini P, Johnson CA (2007) Staging functional damage in glaucoma: review of different classification methods. Surv Ophthalmol 52:156–179CrossRefPubMed Brusini P, Johnson CA (2007) Staging functional damage in glaucoma: review of different classification methods. Surv Ophthalmol 52:156–179CrossRefPubMed
26.
Zurück zum Zitat Sriram P, Klistorner A, Graham S et al (2015) Optimizing the detection of preperimetric glaucoma by combining structural and functional tests. Invest Ophthalmol Vis Sci 56:7794–7800CrossRefPubMed Sriram P, Klistorner A, Graham S et al (2015) Optimizing the detection of preperimetric glaucoma by combining structural and functional tests. Invest Ophthalmol Vis Sci 56:7794–7800CrossRefPubMed
27.
Zurück zum Zitat Leibowitz HM, Krueger DE, Maunder LR et al (1980) The Framingham Eye Study monograph: an ophthalmological and epidemiological study of cataract, glaucoma, diabetic retinopathy, macular degeneration, and visual acuity in a general population of 2631 adults, 1973–1975. Surv Ophthalmol 24:335–610CrossRefPubMed Leibowitz HM, Krueger DE, Maunder LR et al (1980) The Framingham Eye Study monograph: an ophthalmological and epidemiological study of cataract, glaucoma, diabetic retinopathy, macular degeneration, and visual acuity in a general population of 2631 adults, 1973–1975. Surv Ophthalmol 24:335–610CrossRefPubMed
28.
Zurück zum Zitat Klein BE, Klein R, Linton KL (1992) Intraocular pressure in an American community. The Beaver Dam Eye Study. Invest Ophthalmol Vis Sci 33:2224–2228PubMed Klein BE, Klein R, Linton KL (1992) Intraocular pressure in an American community. The Beaver Dam Eye Study. Invest Ophthalmol Vis Sci 33:2224–2228PubMed
29.
Zurück zum Zitat Tielsch JM, Sommer A, Katz J et al (1991) Racial variations in the prevalence of primary open-angle glaucoma. The Baltimore Eye Survey. JAMA 266:369–374CrossRefPubMed Tielsch JM, Sommer A, Katz J et al (1991) Racial variations in the prevalence of primary open-angle glaucoma. The Baltimore Eye Survey. JAMA 266:369–374CrossRefPubMed
30.
Zurück zum Zitat Varma R, Ying-Lai M, Francis BA et al (2004) Prevalence of open-angle glaucoma and ocular hypertension in Latinos: the Los Angeles Latino Eye Study. Ophthalmology 111:1439–48CrossRefPubMed Varma R, Ying-Lai M, Francis BA et al (2004) Prevalence of open-angle glaucoma and ocular hypertension in Latinos: the Los Angeles Latino Eye Study. Ophthalmology 111:1439–48CrossRefPubMed
32.
Zurück zum Zitat Hollows FC, Graham PA (1996) Intra-ocular pressure, glaucoma, and glaucoma suspects in a defined population. Br J Ophthalmol 50:570–586CrossRef Hollows FC, Graham PA (1996) Intra-ocular pressure, glaucoma, and glaucoma suspects in a defined population. Br J Ophthalmol 50:570–586CrossRef
33.
Zurück zum Zitat Leske MC, Connell AM, Schachat AP, Hyman L (1994) The Barbados Eye Study. Prevalence of open angle glaucoma. Arch Ophthalmol 112:821–829CrossRefPubMed Leske MC, Connell AM, Schachat AP, Hyman L (1994) The Barbados Eye Study. Prevalence of open angle glaucoma. Arch Ophthalmol 112:821–829CrossRefPubMed
34.
Zurück zum Zitat Prausnitz MR, Noonan JS (1998) Permeability of cornea, sclera, and conjunctiva: a literature analysis for drug delivery to the eye. J Pharm Sci 87:1479–1488CrossRefPubMed Prausnitz MR, Noonan JS (1998) Permeability of cornea, sclera, and conjunctiva: a literature analysis for drug delivery to the eye. J Pharm Sci 87:1479–1488CrossRefPubMed
35.
Zurück zum Zitat Yasueda S, Higashiyama M, Yamaguchi M et al (2007) Corneal critical barrier against the penetration of dexamethasone and lomefloxacin hydrochloride: evaluation by the activation energy for drug partition and diffusion in cornea. Drug Dev Ind Pharm 33:805–811CrossRefPubMed Yasueda S, Higashiyama M, Yamaguchi M et al (2007) Corneal critical barrier against the penetration of dexamethasone and lomefloxacin hydrochloride: evaluation by the activation energy for drug partition and diffusion in cornea. Drug Dev Ind Pharm 33:805–811CrossRefPubMed
36.
Zurück zum Zitat Tabbara KF, Al-Ghamdi A, Al-Mohareb F et al (2009) Ocular findings after allogeneic hematopoietic stem cell transplantation. Ophthalmology 116:1624–1629CrossRefPubMed Tabbara KF, Al-Ghamdi A, Al-Mohareb F et al (2009) Ocular findings after allogeneic hematopoietic stem cell transplantation. Ophthalmology 116:1624–1629CrossRefPubMed
37.
Zurück zum Zitat Razeghinejad MR, Katz LJ (2012) Steroid-induced iatrogenic glaucoma. Ophthalmic Res 47:66–80CrossRefPubMed Razeghinejad MR, Katz LJ (2012) Steroid-induced iatrogenic glaucoma. Ophthalmic Res 47:66–80CrossRefPubMed
38.
Zurück zum Zitat Garbe E, LeLorier J, Boivin JF et al (1997) Risk of ocular hypertension or open-angle glaucoma in elderly patients on oral glucocorticoids. Lancet 350:979–982CrossRefPubMed Garbe E, LeLorier J, Boivin JF et al (1997) Risk of ocular hypertension or open-angle glaucoma in elderly patients on oral glucocorticoids. Lancet 350:979–982CrossRefPubMed
39.
Zurück zum Zitat Carli L, Tani C, Querci F et al (2013) Analysis of the prevalence of cataracts and glaucoma in systemic lupus erythematosus and evaluation of the rheumatologists’ practice for the monitoring of glucocorticoid eye toxicity. Clin Rheumatol 32:1071–1073CrossRefPubMed Carli L, Tani C, Querci F et al (2013) Analysis of the prevalence of cataracts and glaucoma in systemic lupus erythematosus and evaluation of the rheumatologists’ practice for the monitoring of glucocorticoid eye toxicity. Clin Rheumatol 32:1071–1073CrossRefPubMed
40.
Zurück zum Zitat Alfano J (1963) Changes in the intraocular pressure associated with systemic steroid therapy. Am J Ophthalmol 56:245–247CrossRefPubMed Alfano J (1963) Changes in the intraocular pressure associated with systemic steroid therapy. Am J Ophthalmol 56:245–247CrossRefPubMed
41.
Zurück zum Zitat Adhikary HP, Sells RA, Basu PK (1982) Ocular complications of systemic steroid after renal transplantation and their association with HLA. Br J Ophthalmol 66:290–291CrossRefPubMedPubMedCentral Adhikary HP, Sells RA, Basu PK (1982) Ocular complications of systemic steroid after renal transplantation and their association with HLA. Br J Ophthalmol 66:290–291CrossRefPubMedPubMedCentral
42.
Zurück zum Zitat Holland EJ, Djalilian AR, Sanderson JP (2009) Attenuation of ocular hypertension with the use of topical loteprednol etabonate 0.5% in steroid responders after corneal transplantation. Cornea 10:1139–1143CrossRef Holland EJ, Djalilian AR, Sanderson JP (2009) Attenuation of ocular hypertension with the use of topical loteprednol etabonate 0.5% in steroid responders after corneal transplantation. Cornea 10:1139–1143CrossRef
43.
Zurück zum Zitat Arai S, Arora M, Wang T et al (2015) Increasing incidence of chronic graft-versus-host disease in allogeneic transplantation: a report from the Center for International Blood and Marrow Transplant Research. Biol Blood Marrow Transplant 21:266–274CrossRefPubMedPubMedCentral Arai S, Arora M, Wang T et al (2015) Increasing incidence of chronic graft-versus-host disease in allogeneic transplantation: a report from the Center for International Blood and Marrow Transplant Research. Biol Blood Marrow Transplant 21:266–274CrossRefPubMedPubMedCentral
45.
Zurück zum Zitat Fechtner RD, Godfrey DG, Budenz D et al (2010) Prevalence of ocular surface complaints in patients with glaucoma using topical intraocular pressure-lowering medications. Cornea 29:618–621PubMed Fechtner RD, Godfrey DG, Budenz D et al (2010) Prevalence of ocular surface complaints in patients with glaucoma using topical intraocular pressure-lowering medications. Cornea 29:618–621PubMed
46.
Zurück zum Zitat Mathews PM, Ramulu PY, Friedman DS et al (2013) Evaluation of ocular surface disease in patients with glaucoma. Ophthalmology 120:2241–2248CrossRefPubMed Mathews PM, Ramulu PY, Friedman DS et al (2013) Evaluation of ocular surface disease in patients with glaucoma. Ophthalmology 120:2241–2248CrossRefPubMed
47.
Zurück zum Zitat Jaenen N, Baudouin C, Pouliquen P et al (2007) Ocular symptoms and signs with preserved and preservative-free glaucoma medications. Eur J Ophthalmol 17:341–349PubMed Jaenen N, Baudouin C, Pouliquen P et al (2007) Ocular symptoms and signs with preserved and preservative-free glaucoma medications. Eur J Ophthalmol 17:341–349PubMed
48.
Zurück zum Zitat Pisella PJ, Pouliquen P, Baudouin C (2002) Prevalence of ocular symptoms and signs with preserved and preservative free glaucoma medication. Br J Ophthalmol 86:418–423CrossRefPubMedPubMedCentral Pisella PJ, Pouliquen P, Baudouin C (2002) Prevalence of ocular symptoms and signs with preserved and preservative free glaucoma medication. Br J Ophthalmol 86:418–423CrossRefPubMedPubMedCentral
Metadaten
Titel
Prevalence of ocular hypertension and glaucoma in patients with chronic ocular graft-versus-host disease
verfasst von
Ujwala S. Saboo
Francisco Amparo
Hasanain Shikari
Reza Dana
Publikationsdatum
12.03.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Graefe's Archive for Clinical and Experimental Ophthalmology / Ausgabe 5/2016
Print ISSN: 0721-832X
Elektronische ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-016-3312-3

Weitere Artikel der Ausgabe 5/2016

Graefe's Archive for Clinical and Experimental Ophthalmology 5/2016 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.